Skip to main content
. 2020 Aug 28;21(17):6233. doi: 10.3390/ijms21176233

Table 2.

Effects of various mutations in the OR region of PrPC on hereditary and acquired prion diseases.

Disease Type PrPs Number of the OR Sequence Clinicopathological Features References
Hereditary prion disease PG14 14 1 • Spontaneously develop cerebellar neurodegeneration.
• Accumulate very slightly but substantially PK-resistant PrPScPG14 in the brain.
• No prion infectivity associated with PrPScPG14.
[71,72,73]
Bo10OR-PrP 10 2 • Spontaneously develop cerebellar neurodegeneration.
• Accumulate insoluble and slightly PK-resistant 10OR-PrPSc in their brains.
• No prion infectivity associated with 10OR-PrPSc.
[74]
Disease Type PrPs Number of the OR Sequence Susceptibility to Prions References
Acquired prion disease PrP∆OR 0 1 • Reduced to BSE prions, but not to RML and 22L scrapie prions. [70]
Bo7OR-PrP 7 2 • Increased to BSE prions. [75]
Bo10OR-PrP 10 2 • Increased to BSE prions. [74]
PrP(TetraH>G) 51 (with 4 histidine residues mutated to glycine residues) • Reduced to RML prions. [76]

1 Normal mouse PrPC contains 5 repeats of the OR sequence. 2 Normal bovine PrPC contains 6 repeats of the OR sequence.